Cell transformation assays: Are we barking up the wrong tree?

Alternatives to Laboratory Animals

Volumn 40, Issue 2, 2012, Pages 115-130

  Combes, Robert D ^a  

^a RUSSELL AND BURCH HOUSE   (United Kingdom)

Author keywords

Carcinogenicity; Cell transformation assay; Human carcinogens; Human cell based assays; Metabolic activation; Non genotoxic carcinogens; Predictivity

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ARISTOLOCHIC ACID; ARSENIC; ASBESTOS; AZATHIOPRINE; BENZENE; BLEOMYCIN; CARCINOGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DIETHYLSTILBESTROL; ETOPOSIDE; MELPHALAN;

BIOLOGICAL MONITORING; BIOTRANSFORMATION; CARCINOGENESIS; CARCINOGENICITY; CELL ASSAY; CHROMOSOME ABERRATION; FIBROBLAST; GENOTOXICITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CELL; NONHUMAN; NOTE; OCCUPATIONAL EXPOSURE; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; SCORING SYSTEM;

RODENTIA;

EID: 84864227082     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119291204000211     Document Type: Note

References (73)

1. Benigni, R. (2012). Alternatives to the carcinogenicity bioassay for toxicity prediction: Are we there yet? Expert Opinion on Drug Metabolism & Toxicology 8, 407-417.
2. Preston, R.J. & Williams, G.M. (2005). DNA-reactive carcinogens: Mode of action and human cancer hazard. Critical Reviews in Toxicology 35, 673-683.
3. Knight, A., Bailey, J. & Balcombe, J. (2005). Animal carcinogenicity studies - poor human predictivity. ATLA 34, 19-27.
4. Knight, A., Bailey, J. & Balcombe, J. (2005). Animal carcinogenicity studies - obstacles to human extrapolation. ATLA 34, 29-38.
5. Combes, R., Balls, M., Curren, R., Fischbach, M., Fusenig, N., Kirkland, D., Lasne, C., Landolph, J., LeBoeuf, R., Marquardt, H., McCormick, J., Müller, L., Rivedal, E., Sabbioni, E., Tanaka, N., Vasseur, P. & Yamasaki, H. (1999). Cell transformation assays as predictors of human carcinogenicity. The report and recommendations of ECVAM workshop 39. ATLA 27, 745-767.
6. OECD (2001). OECD Environment Health and Safety Publications Series on Testing and Assessment. No. 31. Detailed Review Paper on Non-Genotoxic Carcinogens Detection: The Performance of In Vitro Cell Transformation Assays, 71pp. Paris, France: Environment Directorate Organisation for Economic Co-operation and Development. Available at: http://www.oecd.org/dataoecd/58/29/ 1898492.pdf (Accessed 31.05.12).
7. Vanparys, P., Corvi, R., Aardema, M.J., Gribaldo, L., Hayashi, M., Hoffmann, S. & Schechtman, L. (2012). Application of in vitro cell transformation assays in regulatory toxicology for pharmaceuticals, chemicals, food products and cosmetics. Mutation Research 744, 111-116.
8. Schechtman, L.M. (2012). Rodent cell transformation assays - a brief historical perspective. Mutation Research 744, 3-7.
9. LeBoeuf, R.A., Kerckaert, K.A., Aardema, M.J. & Isfort, R.J. (1999). Use of Syrian hamster embryo and Balb/c 3T3 cell transformation for assessing the carcinogenicity potential of chemicals. In IARC Scientific Publications No. 146. The Use of Short- and Medium-term Tests for Carcinogenic Hazard Evaluation (ed. D.B. McGregor, J.M. Rice & S. Venitt), pp. 409-425. Lyon, France: International Agency for Research on Cancer.
10. Landolph, J.R. (2005). Chemically induced morphological and neoplastic transformation in C3H/10T1/2 Cl 8 mouse embryo cells. In Molecular Carcinogenesis and the Molecular Biology of Human Cancer (ed. D. Warshawsky & J.R. Landolph), pp. 199-215. London, UK: CRC Press.
11. Sakai, A. (2007). BALB/c 3T3 cell transformation assays for the assessment of chemical carcinogenicity. AATEX 14, Special Issue, 367-373.
12. Kerckaert, G.A., Brauninger, R., LeBoeuf, R.A. & Isfort, R.J. (1996). Use of the Syrian Hamster embryo cell transformation assay for carcinogenicity prediction of chemicals currently being tested by the National Toxicology Program in rodent bioassays. Environmental Health Perspectives 104, 1075-1084. (Pubitemid 26402353)
13. Isfort, R.J., Kerckaert, G.A. & LeBoeuf, R.A. (1996). Comparison of the standard and reduced pH Syrian Hamster Embryo (SHE) cell in vitro transformation assays in predicting the carcinogenic potential of chemicals. Mutation Research 356, 11-63. (Pubitemid 26308722)
14. Mauthe, R.J., Gibson, D.P., Bunch, D.T. & Custer, L. (2001). The Syrian Hamster Embryo (SHE) cell transformation assay: Review of the methods and results. Toxicologic Pathology 29, 138-146.
15. OECD (2006). OECD Environment, Health and Safety Publications Series on Testing and Assessment No. 31. Detailed Review Paper on Cell Transformation Assays for Detection of Chemical Carcinogens, 170pp. Paris, France: Environment Directorate Organisation for Economic Co-operation and Development. Available at: http://www.oecd.org/dataoecd/56/5/37863750.pdf (Accessed 31.05.12).
16. Combes, R., Grindon, C., Cronin, M.T.D., Roberts, D.W. & Garrod, J. (2007). Proposed integrated decision-tree testing strategies for mutagenicity and carcinogenicity in relation to the EU REACH legislation. ATLA 35, 267-287.
17. Shelby, M.D. (1988). The genetic toxicity of human carcinogens and its implications. Mutation Research 204, 3-15.
18. Thybaud, V., MacGregor, J.T., Müller, L., Crebelli, R., Dearfield, K., Douglas, G., Farmer, P.B., Gocke, E., Hayashi, M., Lovell, D.P., Lutz, W.K., Marzin, D., Moore, M., Nohmi, T., Phillips, D.H. & van Benthem, J. (2011). Strategies in case of positive in vivo results in genotoxicity testing. Mutation Research 723, 121-128.
19. Kirkland, D., Pfuhler, S., Tweats, D., Aardema, M., Corvi, R., Darroudi, F., Elhajouji, A., Glatt, H., Hastwell, P., Hayashi, M., Kasper, P., Kirchner, S., Lynch, A., Marzin, D., Maurici, D., Meunier, J.R., Muller, L., Nohynek, G., Parry, J., Parry, E., Thybaud, V., Tice, R., van Benthem, J., Vanparys, P. & White, P. (2007). How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. Mutation Research 628, 31-55.
20. Combes, R.D. (1995). Regulatory genotoxicity testing: A critical appraisal. ATLA 23, 352-379.
21. Pfuhler, S., Kirkland, D., Kasper, P., Hayashi, M., Vanparys, P., Carmichael, P., Dertinger, S., Eastmond, D., Elhajouji, A., Krul, C., Rothfuss, A., Schoening, G., Smith, A., Speit, G., Thomas, C., van Benthem, J. & Corvi, R. (2009). Reduction of use of animals in regulatory genotoxicity testing: Identification and implementation opportunities - Report from an ECVAM workshop. Mutation Research 680, 31-42.
22. Brambilla, G. & Martelli, A. (2004). Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens. Toxicology 196, 1-19.
23. Styles, J.A. (1977). A method for detecting carcinogenic organic chemicals using mammalian cells in culture. British Journal of Cancer 36, 558-563.
24. O'Donovan, M.R. (1982). Some factors influencing the behaviour of BHK 21 Cl 13 cells in soft agar medium. Carcinogenesis 3, 961-962.
25. Pant, K., Bruce, S.W., Sly, J.E., Kunkelmann, T., Kunz-Bohnenberger, S., Poth, A., Engelhardt, G., Schulz, M. & Schwind, K-R. (2012). Prevalidation study of the Syrian hamster embryo (SHE) cell transformation assay at pH 6.7 for assessment of carcinogenic potential of chemicals. Mutation Research 744, 54-63.
26. Maire, M-A., Pant, K., Poth, A., Schwind, K-R., Rast, C., Bruce, S.W., Sly, J.E., Kunz-Bohnenberger, S., Kunkelmann, T., Engelhardt, G., Schulz, M. & Vasseur, P. (2012). Prevalidation study of the Syrian hamster embryo (SHE) cell transformation assay at pH 7.0 for assessment of carcinogenic potential of chemicals. Mutation Research 744, 64-75.
27. Corvi, R., Aardema, M.J., Gribaldo, L., Hayashi, M., Hoffmann, S., Schechtman, L. & Vanparys, P. (2012). ECVAM prevalidation study on in vitro cell transformation assays: General outline and conclusions of the study. Mutation Research 744, 12-19.
28. Muscolo, M.G., Perdichizzi, S., Rotondo, F., Morandi, E., Guerrini, A., Silingardi, P., Vaccari, M., Grilli, S. & Colacci, A. (2010). BALB/c 3T3 cell transformation assay for the prediction of carcinogenic potential of chemicals and environmental mixtures. Toxicology in Vitro 24, 1292-1300.
29. Sasaki, K., Bohnenberger, S., Hayashi, K., Kunkelmann, T., Muramatsu, D., Phrakonkham, P., Poth, A., Sakai, A., Salovaara, S., Tanaka, N., Thomas, B.C. & Umeda, M. (2012). Recommended protocol for the BALB/c 3T3 cell transformation assay. Mutation Research 744, 30-35.
30. Dunkel, V.C., Schechtman, L.M., Tu, A.S., Sivak, A., Lubet, R.A. & Cameron, T.P. (1988). Interlaboratory evaluation of the C3H/10T1/2 cell transformation assay. Environmental Mutagenesis 12, 21-31.
31. Vasseur, P. & Lasne, C. (2012). OECD detailed review paper (DRP) number 31 on "Cell transformation assays for detection of chemical carcinogens": Main results and conclusions. Mutation Research 744, 8-11.
32. Tsutsui, T., Hayashi, N., Maizumi, H., Huff, J. & Barrett, J.C. (1997). Benzene-, catechol-, hydroquinone- and phenol-induced cell transformation, gene mutations, chromosome aberrations, aneuploidy, sister-chromatid exchanges and unscheduled DNA synthesis in Syrian hamster embryo cells. Mutation Research 373, 113-123. (Pubitemid 27037978)
33. Cunningham, M.L. (2002). A mouse is not a rat is not a human: Species differences exist. Toxicological Sciences 70, 157-158.
34. Ashby, J. (2001). Expectations for transgenic rodent cancer bioassay models. Toxicologic Pathology 29, 177-182.
35. Fitzgerald, D.J., Piccoli, C. & Yamasaki, H. (1989). Detection of non-genotoxic carcinogens in the BALB/c 3T3 cell transformation/mutation assay system. Mutagenesis 4, 286-291. (Pubitemid 19188187)
36. Combes, R.D. (2000). The use of structure-activity relationships and markers of cell toxicity to detect non-genotoxic carcinogens. Toxicology in Vitro 14, 387-399.
37. Gibson, D.P., Brauninger, R., Shaffi, H.S., Kerckaert, G.A., LeBoeuf, R.A., Isfort, R.J. & Aardema, M.J. (1997). Induction of micronuclei in Syrian hamster embryo cells: Comparison to results in the SHE cell transformation assay for National Toxicology Program test chemicals. Mutation Research 392, 61-70. (Pubitemid 27327008)
38. Gibson, D.P., Aardema, M.J., Kerckaert, G.A., Carra, G.J., Brauninger, R.M. & LeBoeuf, R.A. (1995). Detection of aneuploidy-inducing carcinogens in the Syrian hamster embryo (SHE) cell transformation assay. Mutation Research 343, 7-24.
39. Long, M.E. (2007). Predicting carcinogenicity in humans: The need to supplement animal-based toxicology. AATEX 14, 553-559.
40. Toraason, M., Bohrman, J.S., Krieg, E., Combes, R.D., Willington, S.E., Zajac, W. & Langenbach, R. (1992). Evaluation of the V79 cell metabolic cooperation assay as a screen for developmental toxicants. Toxicology in Vitro 6, 165-174.
41. Rivedal, E., Mikalsen, S.O. & Sanner, T. (2000). Morphological transformation and effect on gap junction intercellular communication in Syrian hamster embryo cells as screening tests for carcinogens devoid of mutagenic activity. Toxicology in Vitro 14, 185-192. (Pubitemid 30227567)
42. Trosko, J.E. & Chang, C.C. (2001). Role of stem cells and gap junctional intercellular communication in human carcinogenesis. Radiation Research 155, 175-180.
43. Blaha, L., Kapplova, P., Vondracek, J., Upham, B. & Machala, M. (2002). Inhibition of gap-junctional intercellular communication by environmentally occurring polycyclic aromatic hydrocarbons. Toxicological Sciences 65, 43-51. (Pubitemid 34092689)
44. Tweats, D.J., Scott, A.D., Westmoreland, C. & Carmichael, P.L. (2007). Determination of genetic toxicity and potential carcinogenicity in vitro - challenges post the seventh amendment to the European Cosmetics Directive. Mutagenesis 22, 5-13. (Pubitemid 46058637)
45. Breheny, D., Oke, O. & Faux, S.P. (2011). The use of in vitro systems to assess cancer mechanisms and the carcinogenic potential of chemicals. ATLA 39, 233-255.
46. Creton, S., Aardema, M.J., Carmichael, P.L., Harvey, J.S., Martin, F.L., Newbold, R.F., O'Donovan, M.R., Pant, K., Poth, A., Sakai, A., Sasaki, K., Scott, A.D., Schechtman, L.M., Shen, R.R., Tanaka, N. & Yasaei, H. (2012). Cell transformation assays for prediction of carcinogenic potential: State of the science and future research needs. Mutagenesis 27, 93-101.
47. Trevisan, J., Angelov, P.P., Patel, I.I., Najand, G.M., Cheung, K.T., Llabjani, V., Pollock, H.M., Bruce, S.W., Pant, K., Carmichael, P.L., Scott, A.D. & Martin, F.L. (2010). Syrian hamster embryo (SHE) assay (pH 6.7) coupled with infrared spectroscopy and chemometrics towards toxicological assessment. Analyst 135, 3266-3272.
48. Ahmadzai, A.A., Trevisan, J., Pang, W., Patel, I.I., Fullwood, N.J., Bruce, S.W., Pant, K., Carmichael, P.L., Scott, A.D. & Martin, F.L. (2012). Classification of test agent-specific effects in the Syrian hamster embryo assay (pH 6.7) using infrared spectroscopy with computational analysis. Mutagenesis 27, 375-382.
49. Ahmadzai, A.A., Trevisan, J., Fullwood, N.J., Carmichael, P.L., Scott, A.D. & Martin, F.L. (2012). The Syrian hamster embryo (SHE) assay (pH 6.7): Mechanisms of cell transformation and application of vibrational spectroscopy to objectively score endpoint alterations. Mutagenesis 27, 257-266.
50. Coecke, S., Ahr, H., Blaauboer, B.J., Bremer, S., Casati, S., Castell, J., Combes, R., Corvi, R., Crespi, C.L., Cunningham, M.L., Elaut, G., Eletti, B., Freidig, A., Gennari, A., Ghersi-Egea, J-F., Guillouzo, A., Hartung, T., Hoet, P., Ingelman-Sundberg, M., Munn, S., Jassens, W., Ladstetter, B., Leahy, D., Long, A., Meneguz, A., Monshouwer, M., Morath, S., Nagelkerke, F., Pelkonen, O., Ponti, J., Prieto, P., Richert, L., Sabbioni, E., Schaack, B., Steiling, W., Testai, E., Vericat, J-A. & Worth, A. (2006). Metabolism: A bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54. ATLA 34, 49-84.
51. Greb, W. & Strobel, R. (1980). Cell transformation of BHK21c13 cells by various chemicals with and without S-9 mix. Toxicology 17, 157-160.
52. McCarvill, J.T., Lubet, R.A., Schechtman, L.M., Kouri, R.E. & Putman, D.L. (1990). Morphological transformation of BALB/3T3 cells by various procarcinogens in the presence of a rat liver S-9 activation system. Environmental & Molecular Mutagenesis 16, 304-310.
53. Zu-Wei, G., Wen-Zong, W., Wallace, W.E. & Tongman, O. (1992). Induction of micronuclei in BALB/c-3T3 cells by selected chemicals and complex mixtures. Mutation Research 279, 217-222.
54. Stuard, S.B., Kerckaert, G.A. & Lehman-McKeeman, L.D. (1999). Characterisation of the metabolic capacity of Syrian hamster embryo (SHE) cells. Toxicological Sciences 48, 366.
55. Sala, M., Lasne, C., Lu, Y.P. & Chouroulinkov, I. (1987). Morphological transformation in three mammalian cell systems following treatment with 6-nitrochrysene and 6-nitrobenzo[a]pyrene. Carcinogenesis 8, 503-507. (Pubitemid 17127666)
56. Curren, R.D., Kouri, R.E. & Schechtman, L.M. (1981). Studies on metabolic activation of chemicals for cell transformation and mutagenesis. In Advances in Environmental Toxicology - Mammalian Cell Transformation by Chemical Carcinogens, (ed. N. Misra, V. Dunkel & M. Mehlman), pp. 319-354. New York and New Jersey, NY, USA: Academic Press and Senate Press.
57. Poth, A., Heppenheimer, A. & Bohnenberger, S. (2007). Bhas42 cell transformation assay as a predictor of carcinogenicity. AATEX 14, Special Issue, 519-521.
58. Fusenig, N.E. & Boukamp, P. (1998). Multiple stages and genetic alterations in immortalization, malignant transformation, and tumour progression of human skin keratinocytes. Molecular Carcinogenesis 23, 144-158.
59. Boukamp, P., Petrussevska, R.T., Breitkreutz, D., Hornung, J., Markham, A. & Fusenig, N.E. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. Journal of Cell Biology 106, 761-771. (Pubitemid 18089976)
60. Rekus, M.T. (2000). Characterization of Growth and Differentiation of a Spontaneously Immortalized Keratinocyte Cell Line (HaCaT) in a Defined, Serum-free Culture System, 91pp. PhD Thesis, University of Düsseldorf. Düsseldorf, Germany: University of Düsseldorf. Available at: http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-2315/315. pdf (Accessed 18.05.12).
61. Morgan, T.L., Yang, D.J., Fry, D.G., Hurlin, P.J., Kohler, S.K., Maher, V.M. & McCormick, J.J. (1991). Characteristics of an infinite life span diploid human fibroblast cell strain and a near-diploid strain arising from a clone of cells expressing a transfected v-myc oncogene. Experimental Cell Research 197, 125-136.
62. McCormick, J.J. & Maher, V.M. (2011). Malignant transformation of human skin fibroblasts by two alternative pathways. In Human Cell Transformation: Role of Stem Cells and the Microenvironment: 720 (ed. J.S. Rhim & R. Kremer), pp. 191-208. London, UK: Springer Science+Business Media LLC.
63. Colacci, A., Mascolo, M.G., Perdichizzi, S., Quercioli, D., Gazzilli, A., Rotondo, F., Morandi, E., Guerrini, A., Silingardi, P., Grilli, S. & Vaccari, M. (2011). Different sensitivity of BALB/c 3T3 cell clones in the response to carcinogens. Toxicology in Vitro 25, 1183-1190.
64. Anon. (2012). EURL ECVAM Recommendation of 14th March 2012 on Three Cell Transformation Assays Using Syrian Hamster Embryo Cells (SHE) and the BALB/c 3T3 Mouse Fibroblast Cell Line for In Vitro Carcinogenicity Testing, 43pp. Ispra, Italy: European Commission Joint Research Centre Institute for Health and Consumer Protection. Available at: http://ihcp.jrc.ec.europa.eu/our-labs/eurl- ecvam/eurl-ecvam-recommendations/EURLECVAM%20-Recommendation.pdf (Accessed 11.06.12).
65. Turner, S.D., Wijnhoven, S.W., Tinwell, H., Lashford, L.S., Rafferty, J.A., Ashby, J., Vrieling, H. & Fairbairn, L.J. (2001). Assays to predict the genotoxicity of the chromosomal mutagen etoposide - focussing on the best assay. Mutation Research 493, 139-147. (Pubitemid 32539437)
66. Speit, G. (2012). Genotoxicity of Formaldehyde In Vitro and In Vivo. Available at: http://www.scribd.com/doc/91977532/Genotoxicity-of-Formaldehyde- in-Vitro-and-in-Vivo-by-Gunter-Speit (Accessed 11.06.12).
67. Tadashi, H., Machiko, T. & Shozo, T. (1979). Morphological transformation of hamster embryo cells by cancer chemotherapeutic agents. Toxicology Letters 3, 55-60.
68. Stoica, G., Jacobs, R., Koestner, A., O'Leary, M. & Welsch, C. (1991). ENU-induced in vitro neoplastic transformation of rat mammary epithelial cells. Anticancer Research 11, 1783-1792.
69. Henry, E.C., Rucci, G. & Gasiewicz, T.A. (1989). Characterization of multiple forms of the Ah receptor: Comparison of species and tissues. Biochemistry 28, 6430-6440. (Pubitemid 19202034)
70. Okey, A.B. (1990). Enzyme induction in the cytochrome P-450 system. Pharmacology & Therapeutics 45, 241-298.
71. Kamendulis, L.M. & Klaunig, J.E. (2005). Species differences in the induction of hepatocellular DNA synthesis by diethanolamine. Toxicological Sciences 87, 328-336.
72. Lehman-McKeeman, L.D. & Gamsky, E.A. (2000). Choline supplementation inhibits diethanolamine-induced morphological transformation in Syrian hamster embryo cells: Evidence for a carcinogenic mechanism. Toxicological Sciences 55, 303-310.
73. Liehr, J.G. (2000). Is estradiol a genotoxic mutagenic carcinogen? Endocrine Reviews 21, 40-54.